Cooperative Agreement 90ADPI0127
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$2M
Funding Federal Agency
Administration on Aging
Awarding Federal Agency
Office of Grants Management
Federal Grant Program
93.470
Assistance Type
Cooperative Agreement
Place of Performance
Massachusetts, USA
Similar Awards
This $178,776 Cooperative Agreement award, granted by the Administration on Aging under the Department of Health and Human Services' Special Programs for the Aging, Title IV, and Title II, Discretionary Projects (CFDA 93.048) program, supports the University of Massachusetts Boston in developing and testing innovative services and systems that respond to the needs of the growing elderly population. The award, with a performance period from July 1, 2024 to June 30, 2029, will enable UMass...
This federal Project Grant award, valued at $2,399,431.00 and effective August 1, 2024, was issued by the National Institute on Aging (CFDA 93.866 - Aging Research) to the Trustees of Boston University to develop a digital cognitive health resource based on the Boston University Alzheimer's Disease Research Center (BU ADRC) cohort. The key objectives of this project are to: 1) collect and characterize digital cognitive metrics (DCOG) for individuals at high and low risk of Alzheimer's disease,...
This Project Grant award with Federal Grant ID P30AG086562 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award of $2,406,482 to The General Hospital Corporation (doing business as Massachusetts General Hospital) supports the "Massachusetts General Hospital Roybal Center for Behavioral Dyadic Research in Alzheimer's Disease and Related Dementias" (CONFIDE-ADRD) research center. The center aims to develop,...
This Cooperative Agreement award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $828,534 in funding to the University of Massachusetts Medical School (UMass Medical) to conduct a comprehensive molecular-genetic study on the role of the adaptive immune system in the pathogenesis of Alzheimer's disease (AD). The project aims to apply large-scale genomic technologies to analyze tissue samples from AD mouse models and human brain specimens, with the goal of...
The Southern Maine Agency on Aging has been awarded a $959,852 Cooperative Agreement from the U.S. Department of Health and Human Services Administration for Community Living under the Alzheimer's Disease Program Initiative (ADPI) (CFDA 93.470). This 3-year grant, effective September 1, 2024, will support the development and expansion of dementia-capable home and community-based services in Southern Maine to assist individuals with Alzheimer's disease and related dementias (ADRD) and their...
This $498,748 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research program) will fund research at the University of Massachusetts Medical School to elucidate the mechanisms by which the MS4A gene family regulates neurodegeneration in Alzheimer's disease and related disorders. The key objectives of this one-year grant are to: 1) determine the effects of deleting individual or multiple MS4A gene family members on neurodegenerative phenotypes in mouse...
This $287,118 Project Grant was awarded on September 1, 2023 by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) grant program. The grant will fund the development of techniques to use deep transfer learning and multimodal data, including brain MRIs, genetic information, and cognitive tests, to enable the early detection and forecasting of Alzheimer's disease progression. The University of Massachusetts (UMass), as the prime awardee, will create an end-to-end...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
This Cooperative Agreement award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support Boston University Medical Campus in conducting research to identify genetic and molecular mechanisms underlying the effects of the APOE gene on Alzheimer's disease (AD) risk and progression. The $810,698 award, which runs from September 15, 2024 to June 30, 2029, will enable the researchers to: Leverage large genome-wide association study (GWAS) datasets to discover new APOE...
This Cooperative Agreement award from the U.S. Department of Health and Human Services' Administration for Community Living under the National Family Caregiver Support, Title III, Part E (CFDA 93.052) program provides $980,000.00 to the Massachusetts Executive Office of Elder Affairs to implement the National Strategy to Support Family Caregivers. The funding will support a comprehensive system of caregiver support services in Massachusetts, including information dissemination, counseling,...